journal article·2023-02-22Open access

Magnetic Resonance with Diffusion and Dynamic Perfusion-Weighted Imaging in the Assessment of Early Chemoradiotherapy Response of Naso-Oropharyngeal Carcinoma

Michele Pietragalla, Eleonora Bicci, Linda Calistri, Chiara Lorini, Pierluigi Bonomo, Andrea Borghesi, Antonio Lo Casto, Francesco Mungai, Luigi Bonasera, Giandomenico Maggiore, Cosimo Nardi

Applied Sciences· Volume 13· Issue 5

Abstract

The purpose of this study was to differentiate post-chemoradiotherapy (CRT) changes from tumor persistence/recurrence in early follow-up of naso-oropharyngeal carcinoma on magnetic resonance (MRI) with diffusion (DWI) and dynamic contrast-enhanced perfusion-weighted imaging (DCE-PWI). A total of 37 patients were assessed with MRI both for tumor staging and 4-month follow-up from ending CRT. Mean apparent diffusion coefficient (ADC) values, area under the curve (AUC), and K(trans) values were calculated from DWI and DCE-PWI images, respectively. DWI and DCE-PWI values of primary tumor (ADC, AUC, K(trans)pre), post-CRT changes (ADC, AUC, K(trans)post), and trapezius muscle as a normative reference before and after CRT (ADC, AUC, K(trans)muscle pre and muscle post; AUCpost/muscle post:AUCpre/muscle pre (AUCpost/pre/muscle); K(trans)post/muscle post:K(trans)pre/muscle pre (K(trans)post/pre/muscle) were assessed. In detecting post-CRT changes, ADCpost > 1.33 × 10−3 mm2/s and an increase >0.72 × 10−3 mm2/s and/or >65.5% between ADCpost and ADCpre values (ADCpost-pre; ADCpost-pre%) had 100% specificity, whereas hypointense signal intensity on DWIb800 images showed specificity 80%. Although mean AUCpost/pre/muscle and K(trans)post/pre/muscle were similar both in post-CRT changes (1.10 ± 0.58; 1.08 ± 0.91) and tumor persistence/recurrence (1.09 ± 0.11; 1.03 ± 0.12), K(trans)post/pre/muscle values < 0.85 and >1.20 suggested post-CRT fibrosis and inflammatory edema, respectively. In early follow-up of naso-oropharyngeal carcinoma, our sample showed that ADCpost > 1.33 × 10−3 mm2/s, ADCpost-pre% > 65.5%, and ADCpost-pre > 0.72 × 10−3 mm2/s identified post-CRT changes with 100% specificity. K(trans)post/pre/muscle values less than 0.85 suggested post-CRT fibrosis, whereas K(trans)post/pre/muscle values more than 1.20 indicated inflammatory edema.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Head and Neck Cancer Studies · MRI in cancer diagnosis · Bone and Joint Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Radiodiagnostic Unit N. 2, Department of Experimental and Clinical Biomedical Sciences, University of Florence—Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy

Department of Health Science, University of Florence, 50134 Florence, Italy

Radiation Oncology, University of Florence—Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, 25123 Brescia, Italy

Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University Hospital of Palermo, 90127 Palermo, Italy

Department of Radiology, University of Florence—Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy

Department of Otorhinolaryngology, University of Florence—Azienda Ospedaliero-Universitaria Careggi, Via Taddeo Alderotti, 50139 Florence, Italy

References (52)

Show source-provided references
1. A critical evaluation of computed tomography-derived depth of invasion in the preoperative assessment of oral cancer staging10.1016/j.oraloncology.2020.104749 ↗
2. Maraghelli, D., Pietragalla, M., Calistri, L., Barbato, L., Locatello, L.G., Orlandi, M., Landini, N., Casto, A.L., and Nardi, C. (2022). Techniques, Tricks, and Stratagems of Oral Cavity Computed Tomography and Magnetic Resonance Imaging. Appl. Sci., 12.10.3390/app12031473 ↗
3. CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma10.1007/s11547-019-01028-6 ↗
4. Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment changes10.1016/j.oraloncology.2019.06.037 ↗
5. A Critical Reappraisal of Primary and Recurrent Advanced Laryngeal Cancer Staging10.1177/0003489418806915 ↗
6. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience10.1093/annonc/mdh308 ↗
7. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter10.3174/ajnr.A5548 ↗
8. Hypoxia and drug resistance10.1007/BF00689633 ↗
9. Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment
10. A practical overview of CT and MRI features of developmental, inflammatory, and neoplastic lesions of the sphenoid body and clivus10.1007/s00234-022-02986-x ↗
11. Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation10.1007/s00330-020-07163-3 ↗
12. Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications10.3174/ajnr.A4458 ↗
13. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: Potential to guide treatment? A systematic review10.1016/j.oraloncology.2014.07.011 ↗
14. PET-CT surveillance versus neck dissection in advanced head and neck cancer10.1056/NEJMoa1514493 ↗
15. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma10.1016/j.mri.2017.09.015 ↗
16. Texture analysis in the characterization of parotid salivary gland lesions: A study on MR diffusion weighted imaging10.1016/j.ejrad.2021.109529 ↗
17. Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer10.1016/j.mric.2017.08.008 ↗
18. Diffusion-Weighted Imaging in Head and Neck Cancer10.1016/j.mric.2017.08.011 ↗
19. Principles and Applications of Diffusion-weighted Imaging in Cancer Detection, Staging, and Treatment Follow-up10.1148/rg.316115515 ↗
20. Diffusion weighted imaging: Technique and applications10.4329/wjr.v8.i9.785 ↗
21. Magnetic resonance features of sinonasal melanotic mucosal melanoma10.1136/bcr-2019-229790 ↗
22. The role of diffusion-weighted and dynamic contrast enhancement perfusion-weighted imaging in the evaluation of salivary glands neoplasms10.1007/s11547-020-01182-2 ↗
23. Imaging biomarkers in the diagnosis of salivary gland tumors: The value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters10.1007/s11547-021-01376-2 ↗
24. Rajabi, M., and Mousa, S.A. (2017). The Role of Angiogenesis in Cancer Treatment. Biomedicines, 5.10.3390/biomedicines5020034 ↗
25. Dynamic contrast-enhanced MRI in oncology: How we do it10.1007/s11547-020-01220-z ↗
26. The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma10.2967/jnumed.116.174433 ↗
27. Value of Diffusion-Weighted and Perfusion-Weighted MR Imaging in Differentiation of Recurrent Tongue Carcinoma from Post-Treatment Changes10.21608/mjcu.2020.118546 ↗
28. The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: Impact of human papilloma virus oropharyngeal cancer status10.1007/s00432-021-03662-y ↗
29. Development of a Multiparametric Voxel-Based Magnetic Resonance Imaging Biomarker for Early Cancer Therapeutic Response Assessment10.18383/j.tom.2015.00124 ↗
30. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma10.1002/jmri.25523 ↗
31. T2-Weighted MR Imaging Early after Chemoradiotherapy to Evaluate Treatment Response in Head and Neck Squamous Cell Carcinoma10.3174/ajnr.A3378 ↗
32. Head and Neck Squamous Cell Carcinoma: Diagnostic Performance of Diffusion-weighted MR Imaging for the Prediction of Treatment Response10.1148/radiol.12120167 ↗
33. Squamous cell carcinoma of the head and neck: Diffusion-weighted MR imaging for prediction and monitoring of treatment response10.1007/s00330-010-1769-8 ↗
34. Diffusion-Weighted Magnetic Resonance Imaging Early After Chemoradiotherapy to Monitor Treatment Response in Head-and-Neck Squamous Cell Carcinoma10.1016/j.ijrobp.2011.02.044 ↗
35. Brenet, E., Barbe, C., Hoeffel, C., Dubernard, X., Merol, J.-C., Fath, L., Servagi-Vernat, S., and Labrousse, M. (2020). Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy. Cancers, 12.10.3390/cancers12051234 ↗
36. Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck10.1158/1078-0432.CCR-08-1287 ↗
37. Diffusion Weighted Imaging in Predicting Progression Free Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Treated with Induction Chemotherapy10.1016/j.acra.2011.06.009 ↗
38. Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16– High Risk Head and Neck Cancer10.3389/fonc.2019.01118 ↗
39. Fractional Change in Apparent Diffusion Coefficient as an Imaging Biomarker for Predicting Treatment Response in Head and Neck Cancer Treated with Chemoradiotherapy10.3174/ajnr.A3706 ↗
40. The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging10.1016/j.ejrad.2017.05.002 ↗
41. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papilloma-virus-associated squamous cell carcinoma of the oropharynx: Preliminary results form a prospective pilot study10.1002/nbm.3412 ↗
42. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers10.1007/s00330-012-2596-x ↗
43. Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis10.2214/AJR.14.14166 ↗
44. Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors10.1148/rg.2015140029 ↗
45. Van Der Hoorn, A., Van Laar, P.J., Holtman, G.A., and Westerlaan, H.E. (2017). Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis. PLoS ONE, 12.10.1371/journal.pone.0177986 ↗
46. PET/CT in head and neck cancer: An update10.1007/s00259-009-1365-9 ↗
47. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences10.1007/s00330-017-4999-1 ↗
48. Functional magnetic resonance imaging of head and neck cancer: Performance and potential
49. Dynamic contrast-enhanced (DCE) imaging: State of the art and applications in whole-body imaging10.1007/s11604-021-01223-4 ↗
50. Radiation-induced fibrosis: Mechanisms and implications for therapy10.1007/s00432-015-1974-6 ↗
51. D’Urso, P., Farneti, A., Marucci, L., Marzi, S., Piludu, F., Vidiri, A., and Sanguineti, G. (2022). Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI. Cancers, 14.10.3390/cancers14102477 ↗
52. Bicci, E., Nardi, C., Calamandrei, L., Pietragalla, M., Cavigli, E., Mungai, F., Bonasera, L., and Miele, V. (2022). Role of Texture Analysis in Oropharyngeal Carcinoma: A Systematic Review of the Literature. Cancers, 14.10.3390/cancers14102445 ↗